Skip to main content

At Kardium, we are committed to delivering the best treatment for atrial fibrillation.

We are a rapidly growing, privately held medical solutions company with a mission to deliver the best treatment for atrial fibrillation through the Globe® Pulsed Field System.

Founded in 2007 and headquartered in Vancouver, Canada, Kardium has been recognized as a top company to work for in BC.


Our story:
A commitment to innovation

Kardium
Founded

First in Human
Globe Mapping and
Ablation System

GLOBAL-AF
pivotal study

First in Human
Globe Pulsed
Field System

PULSAR
study initiated

FDA
approval received

Kardium Leadership

  • Kevin Chaplin

    Kevin

    Chaplin

    Chief Executive Officer

    Kevin joined Kardium in 2008. He has been active in many areas at Kardium, including product development, marketing, clinical development, business development and financing. Prior to Kardium, Kevin held product management, marketing and technical positions at Kodak, Sierra Wireless and Accenture. He started his career working as an engineer at the deepest gold mine in the world. Kevin has a B.Sc. in Chemical Engineering from the University of Cape Town.

  • Doug Goertzen

    Doug

    Goertzen

    President and Chief Operating Officer

    Doug is a co-founder of Kardium. Prior to Kardium, Doug held the position of General Manager, Proofing and Color at Eastman Kodak Company, and was responsible for the $55M worldwide proofing and colour business and a 130-person team. He held senior positions in service, development and management during his 12 years at Kodak and Creo Inc. (acquired by Kodak in 2005). He graduated with a B.A.Sc. in Electrical Engineering from Simon Fraser University.

  • Koert VandenEnden

    Koert

    VandenEnden

    Chief Financial Officer
  • Daniel Weinkam

    Daniel

    Weinkam

    Vice President, Engineering
  • Stefan Avall

    Stefan

    Avall

    Vice President, Product Management
  • Naghmeh Ghafari

    Naghmeh

    Ghafari

    Vice President, Product Quality Engineering
  • Peter Theobald

    Peter

    Theobald

    Vice President, Supply Chain and Manufacturing
  • Candice Hollingsworth

    Candice

    Hollingsworth

    Vice President, Talent
  • Ricardo Romero

    Ricardo

    Romero

    Vice President, Regulatory Affairs & Quality Assurance

    Ricardo is VP, Regulatory Affairs and Quality Assurance and began his career at Kardium in 2010. Since, he’s played a key role in building Kardium’s QA and RA teams, and has also revamped its QMS to support in-house manufacture of high-risk cardiovascular products. Some of his notable achievements at Kardium include securing a CE marking of the Globe® Mapping and Ablation System and attaining a Premarket Approval (PMA) of the Globe® Pulsed Field System. Ricardo holds a MSc in Biomedical Engineering from the Universidad de Los Andes and has more than a decade of experience in the field as a Director of Quality and Manufacturing and Development Engineer.

    Biggest win at Kardium so far:
    Having developed an amazing, best-in-class product that will have a tremendous impact on the lives of millions of people, worldwide.

Learn more about our Board of Directors

Kardium Board of Directors

  • Kevin Chaplin

    Kevin

    Chaplin

    Chief Executive Officer

    Kevin joined Kardium in 2008. He has been active in many areas at Kardium, including product development, marketing, clinical development, business development and financing. Prior to Kardium, Kevin held product management, marketing and technical positions at Kodak, Sierra Wireless and Accenture. He started his career working as an engineer at the deepest gold mine in the world. Kevin has a B.Sc. in Chemical Engineering from the University of Cape Town.

  • Amos Michelson

    Amos

    Michelson

    Co-founder and Chairman

    Mr. Michelson brings over 20 years of leadership experience to the Chairman position. He is actively involved in the high tech community in Vancouver and around the world, serving on a number of boards. He was CEO of Creo Inc. and a member of the board from 1991 until Kodak purchased Creo for over C$1 Billion in May 2005. Prior to Creo, he was CEO of Opal Inc., a semi-conductor equipment company, and Chief Operating Officer of Optrotech Ltd., a developer and manufacturer of optical and imaging systems for the electronics industry.

    Amos Michelson holds a Master of Business Administration from Stanford Graduate School of Business and a Bachelor of Science in Electrical Engineering from the Technion, Israel Institute of Technology. He is a past member of the Premier’s Technology Council and in 1999 was named “Entrepreneur of the Year” by Ernst & Young. In 2005, Mr. Michelson was named the “BCTIA Person of the Year”, an award presented to an individual who has made an outstanding contribution to the technology industry during the year.

  • Dave Rosa

    Dave

    Rosa

    Director

    David J. Rosa is chief executive officer at Intuitive and a member of the Board of Directors since 2024.

    Rosa joined Intuitive in March 1996 and has held leadership positions in engineering, clinical development, marketing, and product development. In April 2011, Rosa was promoted to the position of senior vice president, emerging procedures and technology, and transitioned to the position of senior vice president, scientific affairs. In August 2014, Rosa was promoted to the position of executive vice president and chief scientific officer. In June 2015, Rosa was appointed as executive vice president and chief commercial officer. In January 2019, he took on additional responsibility as executive vice president and chief business officer. In January 2022, Rosa transitioned to chief strategy and growth officer. In May 2023, Rosa was promoted to the role of president of the company.

    A holder of multiple patents, Rosa earned a BS in mechanical engineering from California Polytechnic University at San Luis Obispo and an MS in mechanical engineering from Stanford University.

  • Manuel Alba

    Manuel

    Alba

    Director

    Mr. Alba was a co-founder, director and President of Galileo Technology from 1994 to 2001, director of Marvell (MRVL) from 2001 to 2004, director of Pixer from 2005 to 2008, director of Annapurna Labs from 2011 to 2015, director of Habana Labs from 2016 to 2020, and director of Banias Labs from 2020 to 2022. During his career, Mr. Alba has worked as a design engineer, technical marketing engineer, technology business executive, and active founding investor. Mr. Alba has also served as a board member of various non-profit organizations. Mr. Alba holds a Bachelor of Science degree in Electrical Engineering from the National Polytechnic Institute in Mexico City, Master of Science degrees in Computer Engineering and Engineering Management from the University of Southern California, and a Master of Business Administration from the University of Santa Clara.

  • Ian Ihnatowycz

    Ian

    Ihnatowycz

    Director

    Ian Ihnatowycz is the President and CEO of First Generation Capital Inc., a private investment holding company. Formerly President and Chief Executive Officer of Acuity Investment Management Inc. and Acuity Funds Ltd., Mr. Ihnatowycz founded Acuity in 1990 to provide discretionary asset management for pension, foundation and private clients as well as mutual and pooled funds. A leader in sustainable investing, Acuity was the first Canadian advisor to the United Nations on the integration of environmental, social and governance factors within investment management, and the firm had won many awards for investment performance. On February 1, 2011, Acuity and its assets of $7.6 billion were sold.

    Mr. Ihnatowycz has served on the boards of numerous not-for-profit and professional organizations and private companies, is currently a member of the Board of Directors of Myca Health Inc., Real Imaging Ltd., Fulcrum Management Solutions Ltd., Acerus Pharmaceuticals Corporation and the Royal Conservatory of Music, is a member of the Ivey Advisory Board, the Ian O. Ihnatowycz Institute for Leadership Advisory Board of the Ivey Business School and a member of the Investment Advisory Committee of Imperial Capital Acquisition Fund V.

    Mr. Ihnatowycz earned a B.Sc. from the University of Toronto, an MBA from the Ivey Business School, holds the CFA and Chartered Director designations, and recently received an Honorary Doctor of Laws degree from Western University.

Learn more about our Leadership

Our team:
Innovation powered by people

We bring together technical excellence, ingenuity, and a shared drive to give physicians the tools they need to deliver the highest standard of care.